NCT Number: NCT00913588
To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted Conditions
To demonstrate the relative bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride capsules (Pulvules) in healthy adult males under fed and fasted conditions.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–45 year
Sex eligibility
Male
Study type
Interventional
Phase
Phase 1
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion criteria
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Treatment and study plan
Fluoxetine HCl 20 mg Capsules Under Fed Conditions (Geneva Pharmaceutical, Inc.)
DrugProzac Fluoxetine HCl 20 mg Capsules Under Fed Conditions (Dista)
DrugPrimary outcomes
-
Bioequivalence based on AUC and Cmax
Time frame: 141 days
Sponsors and collaborators
Lead sponsor
Sandoz
Industry
Registry information
Official study title
Comparative, Randomized, Single-Dose, 3-way Crossover Bioavailability Study of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Health Adult Males Under Fed and Fasted Conditions Following Administration of a 40 mg Dose
Important dates
- Study start
- 1996
- Primary completion
- 1996
- Study completion
- 1996
- First posted
- Jun 4, 2009
- Registry last updated
- Mar 28, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Improving Brain Stimulation Through Imaging
NCT03851380
Behavior, Behavioral Symptoms
Palo Alto, California, United States
View Trial DetailsInvestigating a Mediation Model of Emotion Regulation and Psychological Resilience in Relationship Between Mindfulness and Negative Emotions Among College Students in Guangzhou
NCT07741422
Anxiety, Anxiety Disorders
Guangzhou, Guangdong, China
View Trial DetailsUsing Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
NCT06139016
Behavior, Behavioral Symptoms
New Haven, Connecticut, United States
View Trial DetailsEffectiveness of Integrated Network for Student Psychosocial Intervention, Resilience, and Education (INSPIRE) on Mental Health Outcomes Among Indonesian Adolescents in Bandung
NCT06942637
Adolescents, Anxiety
Bandung, West Java, Indonesia
View Trial Details